Security Snapshot

NEOGENOMICS INC - Common stock ($0.001 par value) (NEO) Institutional Ownership

CUSIP: 64049M209

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

249

Shares (Excl. Options)

133,977,855

Price

$7.42

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,915,992
Value change
+$6,579,873
Number of holders
249
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
129,801,451
SEC-reported price per share
$8.66
Insider filing price
$8.66
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • NEO - NEOGENOMICS INC - Common stock ($0.001 par value) is tracked under CUSIP 64049M209.
  • 249 institutions reported positions in Q1 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 256 to 249 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,540,501,664 to $993,211,566.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 249 institutions filings for Q1 2026.

Open SEC evidence

Security key

64049M209

Latest holder period

Q1 2026

13F holders

249

13D/G owners

9

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
NEO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $145,614,439 18,861,974 BlackRock, Inc. 30 Sep 2025
First Light Asset Management, LLC 11% +41% $115,847,880 +$35,417,243 14,093,416 +44% Mathew P. Arens 30 Apr 2026
Greenhouse Funds LLLP 7.1% +22% $75,754,723 +$14,670,694 9,215,903 +24% Greenhouse Funds LLLP 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9% $56,969,231 7,677,794 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $49,048,218 6,610,272 Vanguard Capital Management 31 Mar 2026
JANUS HENDERSON GROUP PLC 4.8% $63,315,197 6,165,063 JANUS HENDERSON GROUP PLC 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 2.8% -52% $26,073,366 -$24,761,251 3,566,808 -49% Millennium Management LLC 30 Jun 2025
T. Rowe Price Investment Management, Inc. 2.6% $34,067,326 3,317,169 T. Rowe Price Investment Management, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 1.7% -66% $18,271,063 -$35,022,716 2,222,757 -66% Millennium Management LLC 31 Mar 2026

As of 31 Mar 2026, 249 institutional investors reported holding 133,977,855 shares of NEOGENOMICS INC - Common stock ($0.001 par value) (NEO). This represents 103% of the company’s total 129,801,451 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
85%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 19,957,502 +2.5% 0% $148,084,663
First Light Asset Management, LLC 7.5% 9,729,978 -3% 6.5% $72,196,437
Greenhouse Funds LLLP 7% 9,100,103 +5.3% 3.2% $67,522,764
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9% 7,622,187 0% 0% $56,556,628
FIRST TRUST ADVISORS LP 4.7% 6,162,371 0.03% $45,724,792
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 5,655,823 0% 0% $41,966,207
BRAIDWELL LP 4.3% 5,617,402 +21% 1.4% $41,681,123
STATE STREET CORP 3.9% 5,119,838 +2.8% 0% $37,989,198
D. E. Shaw & Co., Inc. 3.2% 4,164,183 -21% 0.02% $30,898,238
SCHRODER INVESTMENT MANAGEMENT GROUP 2.7% 3,568,578 -11% 0.02% $25,693,762
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 2.7% 3,452,587 -12% 0.04% $25,618,000
GEODE CAPITAL MANAGEMENT, LLC 2.5% 3,231,072 +1.7% 0% $23,979,422
BANK OF AMERICA CORP /DE/ 2.4% 3,054,198 +127% 0% $22,662,150
DIMENSIONAL FUND ADVISORS LP 2.1% 2,674,335 +9.2% 0% $19,841,941
SAMLYN CAPITAL, LLC 2% 2,557,349 +84% 0.33% $18,975,530
AMERICAN CAPITAL MANAGEMENT INC 1.7% 2,250,878 -3.2% 0.9% $16,701,515
MILLENNIUM MANAGEMENT LLC 1.7% 2,222,757 -57% 0.01% $16,492,857
GW&K Investment Management, LLC 1.7% 2,190,758 -2.1% 0.14% $16,255,000
MORGAN STANLEY 1.7% 2,162,783 +1.7% 0% $16,047,860
Aberdeen Group plc 1.6% 2,026,893 +13% 0.02% $15,039,546
LOOMIS SAYLES & CO L P 1.5% 1,945,388 +19% 0.02% $14,434,778
PFM Health Sciences, LP 1.4% 1,784,552 +5.3% 1.4% $13,241,376
Driehaus Capital Management LLC 1.3% 1,721,750 -30% 0.09% $12,775,385
NORTHERN TRUST CORP 1.2% 1,580,827 +11% 0% $11,729,737
GLENMEDE TRUST CO NA 1% 1,297,183 -8.1% 0.05% $9,625,096

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 133,977,855 $993,211,566 +$6,579,873 $7.42 249
2025 Q4 130,819,553 $1,540,501,664 +$16,782,695 $11.76 256
2025 Q3 128,856,828 $995,144,233 +$13,772,890 $7.72 251
2025 Q2 127,102,311 $928,960,411 -$11,861,045 $7.31 269
2025 Q1 126,074,888 $1,197,235,152 +$20,732,141 $9.49 248
2024 Q4 122,630,250 $2,020,773,423 -$19,292,481 $16.48 247
2024 Q3 123,905,582 $1,824,489,746 -$30,173,686 $14.75 265
2024 Q2 125,764,461 $1,744,349,407 -$25,594,791 $13.87 253
2024 Q1 128,566,414 $2,021,077,127 +$40,223,752 $15.72 260
2023 Q4 125,750,435 $2,034,740,144 +$91,247,148 $16.18 282
2023 Q3 120,319,823 $1,480,068,392 +$31,109,122 $12.30 278
2023 Q2 117,354,505 $1,887,976,537 +$17,892,372 $16.07 261
2023 Q1 116,149,860 $2,022,087,874 +$68,408,756 $17.41 250
2022 Q4 112,517,309 $1,039,664,895 +$6,813,825 $9.24 235
2022 Q3 112,517,984 $968,760,212 -$61,344,388 $8.61 236
2022 Q2 117,343,229 $956,378,739 +$558,727 $8.15 222
2022 Q1 110,849,435 $1,347,014,006 -$178,663,861 $12.15 262
2021 Q4 117,712,710 $4,016,513,724 +$21,819,286 $34.12 302
2021 Q3 115,633,668 $5,577,437,288 +$212,796,154 $48.24 318
2021 Q2 111,349,475 $5,028,565,162 +$185,109,189 $45.17 308
2021 Q1 108,007,395 $5,210,316,095 +$250,630,845 $48.23 326
2020 Q4 103,918,826 $5,595,174,116 +$117,101,727 $53.84 336
2020 Q3 101,942,927 $3,761,276,674 -$19,415,173 $36.89 287
2020 Q2 102,197,271 $3,169,534,118 +$257,605,485 $30.98 278
2020 Q1 94,250,581 $2,602,301,782 +$27,489,034 $27.61 268
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .